Carderock Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pitney Bowes
PBI
|
+$39.5K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.4K |
| 3 |
Estee Lauder
EL
|
+$24.5K |
| 4 |
Labcorp
LH
|
+$17.4K |
| 5 |
L3Harris
LHX
|
+$6.97K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gartner
IT
|
+$4.15M |
| 2 |
Fortive
FTV
|
+$3.6M |
| 3 |
Check Point Software Technologies
CHKP
|
+$3.5M |
| 4 |
Phillips 66
PSX
|
+$3.02M |
| 5 |
Apple
AAPL
|
+$2.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.39% |
| 2 | Healthcare | 20.72% |
| 3 | Industrials | 9.38% |
| 4 | Financials | 7.95% |
| 5 | Consumer Staples | 7.31% |
Similar funds
Carderock Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Carderock Capital Management held 77 positions worth $218M, down 27% from $298M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Carderock Capital Management withdrew a net $37.6M in Q1 2020, closing 10 positions and reducing 57 holdings. Its most notable exit was Gartner, an estimated $4.15M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Carderock Capital Management opened a new position in Pitney Bowes worth $24K.
- Carderock Capital Management's largest Q1 2020 buy was Pitney Bowes: 11,530 shares worth $24K.
- Carderock Capital Management added most to Bristol-Myers Squibb in Q1 2020, an estimated $28.4K increase.
- Carderock Capital Management's biggest Q1 2020 reduction was Apple, cutting an estimated $2.02M.
- Carderock Capital Management fully exited Gartner in Q1 2020, selling an estimated $4.15M.
- Carderock Capital Management's ten largest holdings make up 31% of its $218M portfolio in Q1 2020.
- Carderock Capital Management opened 1 new position and closed 10 in Q1 2020.
- Carderock Capital Management's portfolio value fell 27% quarter-over-quarter to $218M.
Based on Carderock Capital Management's 13F filing for Q1 2020, filed 11 May 2020.